Skip to main content
Enter your keywords
User account menu
Log in
Main navigation
About
History & Impact
Mission & Values
Leadership
Support SWOG
Join SWOG
Policies & Procedures
Careers
Contact Us
The SWOG Network
How We Work
Our Staff
Our Advocates
Our Partners
News & Events
News
SWOG Stories
SWOG Meetings
For Press
Clinical Trials
Biospecimen Submission
Biospecimen Access
Clinical Trials Search
Clinical Research Resources
Frequently Asked Questions
Publications
Institutions
Quality Assurance & Audits
Serious Adverse Events
Training Resources
CRA Workbench
Protocol Workbench
For Patients
Patient & Advocate Voices
Trials Open to Patients
About SWOG Cancer Trials
Joining a Trial
Glossary
Section navigation
Recent Updates
5/15/2024
5/1/2024
4/15/2024
4/1/2024
3/15/2024
3/1/2024
2/15/2024
2/1/2024
1/15/2024
1/1/2024
12/15/2023
12/1/2023
All Updates
Breadcrumb
SWOG
Member Resources
Trial & Business Updates
Cancer Survivorship
Priority List Cancer Survivorship
S1501
III
Prospective Evaluation of Carvedilol vs No treatment in Prevention of Cardiac Dysfunction in Patients with Metastatic HER-2+ Breast Cancer.